New for ATC 2021
State-of-the-Art Speaker Recommendations
Submission Deadline: July 27, 2020, 11:59 PM PST
The ATC 2021 Program Planning Committee is soliciting Ideas and Recommendations for State-of-the-Art Speakers.
If you know a professional who is a cutting-edge thought-leader in the transplantation industry, then nominate them as a State-of-the-Art Speaker! Submit your nominee by July 27, 2020.
Speaker Submission Information:
- Speaker Name, Company / Institution, Country of Origin, Email Address
- Link to Online Speaker Website and / or Bio
- Links to Online Videos of Speaker Presentations
- Propsoed Speaker Presentation Topic / Title
The ATC 2021 Program Planning Committee will make all final speaker selections. Submitting proposed names and topics for an ATC 2021 State-of-the-Art presentation does not guarantee selection. Please do not contact any speakers on participation.
2020 Virtual Congress
Paul I. Terasaki State-of-the-Art Lecture
Sponsored by the Paul I. Terasaki Research Fund
Live Broadcast Recording Available
in the Virtual Congress Portal
Saturday, May 30, 2020
Immune Management of the Transplant Recipient
Allan D. Kirk, MD, PhD
David C. Sabiston, Jr. Distinguished Professor & Chair
Department of Surgery
Vice Dean for Surgical Disciplines
Duke University School of Medicine
Duke University Health System
American Journal of Transplantation
Allan D. Kirk received his MD and PhD in Immunology from Duke University, where he also completed his surgery residency. He completed a multiorgan transplant fellowship at the University of Wisconsin, during which time he began his longstanding work on costimulation blockade and personalized immune management. He advanced this work as Chief of Transplant Research for the Armed Services Transplant Service in Washington, DC, and subsequently as Chief of the intramural organ transplant program at the National Institutes of Health. In 2007, he moved to Emory University, as Vice Chair for Surgical Research, and in 2014, was appointed Chairman of the Department of Surgery at Duke University. He holds Professorships in Surgery, Pediatrics and Immunology and serves as Surgeon-in-Chief for the Duke University Health System.
In addition to his clinical transplant practice, he has published over 300 scientific manuscripts, and continues NIH-, DoD- and FDA-sponsored investigations in organ transplantation and immune management. He has focused increasingly on the curation and analysis of multidimensional data for use in Real World Evidence trial design, clinical decision support tool development and drug discovery.
He has served as the Editor-in-Chief of the American Journal of Transplantation since 2010, is a member of the AST and ASTS, and is an elected member of the National Academy of Medicine.